CoChat

MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If

Open access
Schenk, Barbara, Imbach, Timo, Frank, Christian G., Grubenmann, Claudia E., Raymond, Gerald V., Hurvitz, Haggit, Raas-Rotschild, Annick, Luder, Anthony S., Jaeken, Jaak, Berger, Eric G., Matthijs, Gert, Hennet, Thierry, Aebi, Markus · 2001 · Journal of Clinical Investigation
Cited by 41

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

IntroductionCongenital disorders of glycosylation (CDG) are a family of severe inherited diseases caused by a defect in protein N-glycosylation (1-4).These multisystem disorders present with a wide variety of clinical features, such as disorders of the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency.The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions (5,6).Isoelectric focusing of serum transferrin, a sialylated glycoprotein, is used as a diagnostic tool and makes it possible to distinguish two basic types of CDG: deficiencies in assembly of the core oligosaccharide or its transfer to protein are referred to as CDG-I and defects in trimming and modification of the core oligosaccharide after its transfer to protein are referred to as CDG-II (7).Several subtypes of CDG have been characterized at the biochemical and genetic level, such as the deficiency in phosphomannomutase activity, caused by a defect in the PMM2 gene (CDG-Ia) (8, 9), the deficiency in the phosphomannose isomerase activity due to a mutated PMI locus (CDG-Ib) (10, 11), mutations in the ALG6 gene resulting in a reduced dolichylphosphoglucosedependent (Dol-P-Glc-dependent) α1,3-glucosyltransferase activity (CDG-Ic) (12-15), mutations in the ALG3 gene leading to a reduced dolichylphosphomannose-dependent (Dol-P-Man-dependent) α1,3-mannosyltransferase activity (CDG-Id) (16), and a defect in the Dol-P-Man synthase activity due to mutations in the DPM1 gene (CDG-Ie) (17, 18).Furthermore, a deficiency in the Golgi enzyme N-acetylglucosaminyltransferase II leads to CDG-IIa (19), mutations in the glucosidase I gene lead to CDG-IIb (20), and an impaired transport of GDP-fucose into the Golgi apparatus causes CDG-Iic (21).The assembly of the dolichylpyrophosphate-linked oligosaccharide core is a highly conserved process that

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci13419

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 44

  1. Freeze, 1999, Biochim Biophys Acta, 1455, 167, 10.1016/S0925-4439(99)00072-1 · DOI
  2. Krasnewich, 1997, Adv Pediatr, 44, 109, 10.1016/S0065-3101(24)00050-1 · DOI · Paper page
  3. 10.1093/glycob/3.2.97 · DOI · Paper page
  4. Aebi, 2000, Glycobiology, 10, III-V
  5. 10.1016/0014-5793(95)01357-1 · DOI · Paper page
  6. 10.1038/ng0597-88 · DOI · Paper page
  7. 10.1086/301873 · DOI · Paper page
  8. 10.1172/JCI2266 · DOI · Paper page
  9. 10.1073/pnas.96.12.6982 · DOI · Paper page
  10. 10.1007/s004390050022 · DOI
  11. 10.1073/pnas.95.22.13200 · DOI · Paper page
  12. 10.1093/emboj/18.23.6816 · DOI
  13. 10.1172/JCI8691 · DOI · Paper page
  14. 10.1172/JCI7302 · DOI · Paper page
  15. Jaeken, 1994, Arch Disease Childhood, 71, 123, 10.1136/adc.71.2.123 · DOI · Paper page
  16. 10.1086/302948 · DOI · Paper page
  17. 10.1074/jbc.274.37.25986 · DOI · Paper page
  18. Burda, 1999, Biochim Biophys Acta, 1426, 239, 10.1016/S0304-4165(98)00127-5 · DOI · Paper page
  19. 10.1146/annurev.bi.56.070187.000431 · DOI · Paper page
  20. 10.1006/bbrc.1999.1886 · DOI
  21. Silberstein, 1996, FASEB J, 10, 849, 10.1096/fasebj.10.8.8666161 · DOI · Paper page
  22. Knauer, 1999, Biochim Biophys Acta, 1426, 259, 10.1016/S0304-4165(98)00128-7 · DOI · Paper page
  23. 10.1074/jbc.R000022200 · DOI · Paper page
  24. Anand, 2001, Mol Biol Cell, 12, 487, 10.1091/mbc.12.2.487 · DOI · Paper page
  25. 10.1002/elps.1150090921 · DOI
  26. Zufferey, 1995, EMBO J, 14, 4949, 10.1002/j.1460-2075.1995.tb00178.x · DOI · Paper page
  27. 10.1002/bmc.1130030106 · doi:10.1002/bmc.1130030106
  28. 10.1093/nar/18.12.3587 · DOI · Paper page
  29. Yamashita, 1993, J Biol Chem, 268, 5783, 10.1016/S0021-9258(18)53387-1 · DOI · Paper page
  30. 10.1093/glycob/9.6.617 · DOI · Paper page
  31. Herscovics, 1999, Biochim Biophys Acta, 1426, 275, 10.1016/S0304-4165(98)00129-9 · DOI
  32. 10.1042/0264-6021:3480001 · doi:10.1042/0264-6021:3480001 · Paper page
  33. 10.1083/jcb.98.1.35 · doi:10.1083/jcb.98.1.35
  34. Rosenwald, 1989, Mol Cell Biol, 9, 914, 10.1128/MCB.9.3.914 · DOI
  35. 10.1016/0163-7827(85)90008-6 · DOI · Paper page
  36. Zeng, 1990, J Biol Chem, 265, 2296, 10.1016/S0021-9258(19)39975-2 · DOI
  37. Camp, 1993, J Biol Chem, 268, 6721, 10.1016/S0021-9258(18)53309-3 · doi:10.1016/s0021-9258(18)53309-3
  38. 10.1083/jcb.130.3.529 · DOI
  39. 10.1093/glycob/8.12.1195 · DOI
  40. Chojnacki, 1988, Biochem J, 251, 1, 10.1042/bj2510001 · DOI · Paper page
  41. Valtersson, 1985, J Biol Chem, 260, 2742, 10.1016/S0021-9258(18)89424-8 · DOI · Paper page
  42. 10.1093/glycob/4.6.909 · doi:10.1093/glycob/4.6.909
  43. Lehrman, 1989, J Biol Chem, 264, 1584, 10.1016/S0021-9258(18)94227-4 · doi:10.1016/s0021-9258(18)94227-4
  44. 10.1093/glycob/10.1.77 · DOI

Cited by

See all 41

Metadata

Authors
Schenk, B., Imbach, T., Frank, C. G., Grubenmann, C. E., Raymond, G. V., Hurvitz, H., Raas-Rotschild, A., Luder, A. S., Jaeken, J., Berger, E. G., Matthijs, G., Hennet, T., & Aebi, M.
Venue
Journal of Clinical Investigation
Published
2001-12-01
Volume
108
Issue
11
Pages
1687-1695
ISSN
0021-9738 (ISSN-L)
OpenAlex
W4255361792
Cited by
41
References
4
FWCI
0.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. https://app.cochat.ai/papers/10.1172/jci13419
The paper
Schenk, B., Imbach, T., Frank, C. G., Grubenmann, C. E., Raymond, G. V., Hurvitz, H., Raas-Rotschild, A., Luder, A. S., Jaeken, J., Berger, E. G., Matthijs, G., Hennet, T., & Aebi, M. (2001). MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. Journal of Clinical Investigation. https://doi.org/10.1172/jci13419

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.